Cancer Genetics Services in the UK

نویسنده

  • Shirley V. Hodgson
چکیده

The National Health Service is the principal provider of free healthcare services, through general practitioners offering primary care to a network of District and Regional or University Teaching hospitals. Medical Genetics has a long history in the UK, although it was not recognised formally until the 1970s. Regional Genetics Centres, providing an integrated clinical and laboratory service, have been established for many years. Most also operate “outreach” clinics at satellite hospitals, or dedicated joint specialist clinics. There are 25 Regional Genetics Centres, each serving a population of 3–6 million: in 1997 they had 79 specialist clinicians (with 55 trainees), and 107 Genetic Counsellors. Genetic counselling is offered by Consultant Clinical Geneticists (with specialist training), supported by Specialist Registrars in Clinical Genetics and Genetic Nurses or Counsellors. Since the 1970s the UK has had several counsellors attached to each Regional Genetics Centre. In many centres they provide full genetic counselling for many conditions, with the support of a discussion departmental framework. Genetic Counsellors are valuable members of the clinical genetics team, who play a considerable role in the provision of counselling service, thereby reducing the workload of Consultants and Registrars, who can then target particular aspects of the service. Laboratory diagnostic services are integral parts of the Regional Genetics Centres. In 1997 there were 408 cytogeneticists (with 106 trainees) and 101 molecular geneticists (with 31 trainees). There is now a clear process of laboratory accreditation. The UK network of molecular genetics centres has rationalised testing for mutations in specific genes in certain centres only, by agreement. However, the patenting of genes such as BRCA1 and BRCA2 is likely to have a profound impact on the costs and management of cancer services, and could result in “rationing” of tests to very high-risk families only.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Planning and Developing Services for Diabetic Retinopathy in Sub-Saharan Africa

Background Over the past few decades diabetes has emerged as an important non-communicable disease in SubSaharan Africa (SSA). Sight loss from Diabetic Retinopathy (DR) can be prevented with screening and early treatment. The objective of this paper is to outline the required actions and considerations in the planning and development of DR screening services.   Methods A multiple-case study app...

متن کامل

Cancer Genetics Services in Europe

S. Hodgson, B. Milner, I. Brown, G. Bevilacqua, J. Chang-Claude, D. Eccles, G. Evans, H. Gregory, P. Møller, P. Morrison, M. Steel, D. Stoppa-Lyonnet, H. Vasen and N. Haites Division of Medical and Molecular Genetics, Guy’s Hospital, London Bridge, London SE1 9RT, UK Medical Genetics, Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK Institute ...

متن کامل

Study of FGF14 gene expression and cancer progression in colorectal cancer tissue samples

Background: Colorectal cancer is one of the main causes of cancer death and the third most common malignant cancer worldwide. FGF14 is a member of the large family of fibroblast growth factors. These factors control a wide range of biological functions, including cell proliferation, survival, migration and differentiation that disturbing their expression can lead to cancer. The purpose of this ...

متن کامل

Cancer Genetics Services in Northern Ireland

Northern Ireland, like Wales and Scotland, is part of the United Kingdom. The total population in 1997 was 1,577,835. The health care structure is similar to the rest of the UK and Northern Ireland constitutes a complete health care region within the UK. It is divided into four area health and social services boards, each providing health and social care and responsible to the Northern Ireland ...

متن کامل

Efficacy of insulin targeted gene therapy for type 1 diabetes mellitus: A systematic review and meta-analysis of rodent studies

Objective(s): Diabetes mellitus (DM) is a major worldwide public health challenge, for which gene therapy offers a potential therapeutic approach. To date, no systematic review or meta-analysis has been published in this area, so we examined all relevant published studies on rodents to elucidate the overall effects of gene therapy on bodyweight, intraperitoneal glucose...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 15  شماره 

صفحات  -

تاریخ انتشار 1999